Navigation Links
Elsevier and International Society of Geriatric Oncology launch Journal of Geriatric Oncology
Date:7/6/2010

Oxford, UK, 6 July, 2010 Elsevier, the world-leading publisher of scientific, technical and medical information products and services, and the International Society of Geriatric Oncology (SIOG) announced today the launch of the Journal of Geriatric Oncology (www.geriatriconcology.net). The journal is focused on advancing research in the pathogenesis, biology, treatment, and survivorship issues of older adults with cancer. It covers all aspects of geriatric oncology, from basic scientific research through to clinical research, as well as research that is relevant to education and policy development.

"Older adults represent the majority of individuals with cancer, and the number of older individuals with cancer is growing as our society ages and life expectancy increases. Despite such a compelling need for geriatric oncology research, it has been challenging to disseminate this research into mainstream geriatric or oncology journals," said Dr Arti Hurria, Editor-in-Chief of the Journal of Geriatric Oncology.

Matti Aapro, Executive Director of SIOG and Founding Editor of the Journal of Geriatric Oncology noted, "It is imperative that chronologic age alone does not prevent senior adult patients from receiving treatment and care for their cancer, which is in line with best practice. To achieve this goal, there was clearly a need for a journal specialized in geriatric oncology. Thus, Elsevier and the International Society for Geriatric Oncology decided that it was time to launch the Journal of Geriatric Oncology, which should become the leading source of updated information in this complex area."

The Editorial Board is led by Editor-in-Chief, Arti Hurria, and Founding Editor, Matti Aapro. Dr Hurria is a geriatrician and oncologist, focusing on care of the older patient with cancer. She completed a geriatric fellowship in the Harvard Geriatric Fellowship Program, followed by a hematology-oncology fellowship at Memorial Sloan-Kettering Cancer Center (MSKCC). Dr Hurria subsequently joined the faculty at MSKCC, and in 2006 joined the City of Hope as Director of the Cancer and Aging Research Program. Dr. Hurria is a cadre member of the Cancer and Leukemia Group B, Cancer in the Elderly Committee and is a recipient of the Paul Beeson Career Development Award in Aging Research (K23 AG026749-01) and American Society of Clinical Oncology-Association of Specialty Professors-Junior Development Award in Geriatric Oncology.

Dr Aapro is Dean of the Multidisciplinary Oncology Institute at the Clinique de Genolier in Genolier, Switzerland. In addition to his role as Executive Director of SIOG, Dr. Aapro is also an active member of several professional organizations. He is a Board member and past-President of the Multinational Association for Supportive Care in Cancer (MASCC) and a member and past-Chair of the Cancer in the Elderly Task Force of the European Organization for Research and Treatment of Cancer (EORTC).


'/>"/>

Contact: Sarah Jenkins
sl.jenkins@elsevier.com
44-186-584-3243
Elsevier
Source:Eurekalert

Related medicine news :

1. Elsevier acquires Collexis
2. Elsevier and InfoDesk collaborate to co-develop federated drug pipeline intelligence solution
3. Elsevier introduces Cardiac Electrophysiology Clinics
4. Elsevier launches Carpentiers reconstructive valve surgery book
5. Elseviers Journal of Evidence-Based Dental Practice celebrates 10th year with special issue
6. Elseviers new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content
7. Elsevier introduces innovative new pharmacology text
8. Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog
9. International News Channel Profiles Egg Donor Surrogacy USA
10. KYSS International creates worldwide buzz by announcing plans for global expansion
11. HCL Supports Reform of Language Testing for International Doctors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... June 27, 2017 , ... PR ... an upcoming case studies guidebook. This guidebook offers an excellent branding and exposure ... include articles, case studies and how-to’s that fall into the following categories:, ...
(Date:6/27/2017)... ... , ... Dr. Richard Amato, a respected periodontist in Monroe, CT, ... Implant Center of Connecticut. As part of the renovation, the cutting-edge practice added two ... to improve patient comfort while making it possible for Dr. Amato to provide even ...
(Date:6/27/2017)... North Hollywood, CA (PRWEB) , ... June 27, ... ... on orthodontic treatments . Orthodontics is a dental specialty that focuses on ... other appliances. Benefits include improved aesthetics and function. , North Hollywood ...
(Date:6/26/2017)... ... June 26, 2017 , ... Torrance dentist, Dr. Robert ... be one of the most noticeable aspects of a person’s appearance. A healthy, radiant ... is born with beautiful, balanced teeth, everyone can have the smile of their dreams ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Centers for Advanced ... hiring of Richard Robinson as chief operating officer (COO). In this role, Robinson ... proven track record of simplifying business processes and developing growth strategies to increase ...
Breaking Medicine News(10 mins):
(Date:6/20/2017)... HILLS, Calif. , June 20, 2017 SkylineDx ... the use of MMprofiler with SKY92, the company,s prognostic ... In a poster presentation at the 22 nd ... Madrid, Spain , SkylineDx researchers will demonstrate ... patients. In a separate e-poster presentation ...
(Date:6/14/2017)... HAMPTON, Va. , June 14, 2017  ivWatch ... safety and effectiveness of intravenous (IV) therapy, is pleased ... in the category of Nonsurgical Hospital Supplies and Equipment ... premier awards program for the medtech industry. The award ... at the Jacob K. Javits Center in ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: